This study aimed to describe healthcare utilisation and costs associated with the assessment of suspected acute coronary syndrome (ACS) under standard care and to compare these outcomes with the Limit of Detection in Emergency Department (LEGEND) strategy, an accelerated diagnostic pathway identifying low‐risk patients using a single highly sensitive troponin (hs‐cTnI). The gene discussed is TNNI3; the disease is acute coronary syndrome.